| Product Code: ETC6666995 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Small Molecule Drug Discovery Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 Canada Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 Canada Small Molecule Drug Discovery Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.6 Canada Small Molecule Drug Discovery Market Revenues & Volume Share, By Process/Phase, 2021 & 2031F |
4 Canada Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring new drug discoveries |
4.2.2 Technological advancements in small molecule drug discovery techniques |
4.2.3 Growing investment in research and development activities in Canada |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with drug discovery and development |
4.3.3 Limited availability of skilled professionals in the field |
5 Canada Small Molecule Drug Discovery Market Trends |
6 Canada Small Molecule Drug Discovery Market, By Types |
6.1 Canada Small Molecule Drug Discovery Market, By Therapeutic Area |
6.1.1 Overview and Analysis |
6.1.2 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Therapeutic Area, 2021- 2031F |
6.1.3 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.1.5 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.6 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.1.7 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.1.8 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.2 Canada Small Molecule Drug Discovery Market, By Process/Phase |
6.2.1 Overview and Analysis |
6.2.2 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Target ID/Validation, 2021- 2031F |
6.2.3 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Hit Generation and Selection, 2021- 2031F |
6.2.4 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Lead Identification, 2021- 2031F |
6.2.5 Canada Small Molecule Drug Discovery Market Revenues & Volume, By Lead Optimization, 2021- 2031F |
7 Canada Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 Canada Small Molecule Drug Discovery Market Export to Major Countries |
7.2 Canada Small Molecule Drug Discovery Market Imports from Major Countries |
8 Canada Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Research and development expenditure in the pharmaceutical sector |
8.2 Number of patents filed for small molecule drug discoveries |
8.3 Success rate of clinical trials for small molecule drugs |
8.4 Number of collaborations between research institutions and pharmaceutical companies |
8.5 Adoption rate of innovative technologies in small molecule drug discovery |
9 Canada Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 Canada Small Molecule Drug Discovery Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.2 Canada Small Molecule Drug Discovery Market Opportunity Assessment, By Process/Phase, 2021 & 2031F |
10 Canada Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 Canada Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Canada Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |